GSK-200363

Study Sponsor: GSK

Study Title

An open-label study to characterize the pharmacokinetics and pharmacodynamics of mepolizumab administered subcutaneously in children from 6 to 11 years of age with severe eosinophilic asthma

Medicine or Vaccine (generic name)

mepolizumab

Sponsor Identification Number

200363

Trial Registry Identification Number(#'s)

NCT02377427 2014-002666-76

Medical Condition

Asthma

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=200363

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02377427

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2014-002666-76

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

September 2019